Hit enter to search or ESC to close
ERA4TB
  • The Project
  • Consortium
  • News
    • Events
    • Press
    • Newsletter
    • Video Library
  • Results
  • TB Facts
  • SharePoint
News

ERA4TB welcomes CIM – Sant Pau (IIB Sant Pau) as New Partner

ERA4TB announced on the 4th Consortium Meeting that CIM – Sant Pau (IIB Sant Pau)…
IT Synapse
IT SynapseFebruary 1, 2022
News

The ERA4TB Scientific Advisory Board has been set up

Dr Gilla Kaplan, Ph.D. Former Director of the Global Health Program, Tuberculosis, at the Bill…
IT Synapse
IT SynapseFebruary 1, 2022
Event

ERA4TB 4th Consortium Meeting: The Time to Make a Difference

On the 27th and 28th of January 2022, Consortium members gathered virtually for two days…
IT Synapse
IT SynapseJanuary 31, 2022
News

ERA4TB SCHEDULES THE 4TH CONSORTIUM MEETING ON 27TH AND 28TH OF JANUARY 2022

The ERA4TB 4th Consortium Meeting is taking place next 27th -28th January 2022 as a…
Inari Soininen
Inari SoininenDecember 3, 2021
Press

Advancing Clinical Research Capacity in Europe: Almari Conradie on TBAJ-587 and the ERA4TB Project [TB Alliance]

TBAJ-587-CL-001 is the first Phase 1 trial in humans conducted by TB Alliance through the…
Inari Soininen
Inari SoininenNovember 26, 2021
Event

Project Update – 3th Consortium Meeting

The third ERA4TB Consortium Meeting took place last June 9th and 10th with the participation…
Inari Soininen
Inari SoininenJune 15, 2021
Press

COVID-19 highlights urgent need to reboot global effort to end tuberculosis [Press Release – WHO]

An estimated 1.4 million fewer people received care for tuberculosis (TB) in 2020 than in…
Inari Soininen
Inari SoininenMarch 26, 2021
Event

Consortium Meeting

On January 26th and 27th the second Consortium Meeting took place online to share the…
Inari Soininen
Inari SoininenFebruary 2, 2021
News

TB Alliance Announces First Patient Dosed with TBAJ-587 in Phase 1 Study

TB Alliance announced that on December 1, 2020, the first dose was administered to a…
IT Synapse
IT SynapseDecember 17, 2020
Event

Europa Press Digital Meetings: AIDS, tuberculosis and malaria in times of COVID-19

As part of their online initiative to allow experts to discuss a variety of topics,…
Inari Soininen
Inari SoininenNovember 30, 2020
1 2 Next

Recent Posts

  • ERA4TB welcomes CIM – Sant Pau (IIB Sant Pau) as New Partner
  • The ERA4TB Scientific Advisory Board has been set up
  • ERA4TB 4th Consortium Meeting: The Time to Make a Difference
  • ERA4TB SCHEDULES THE 4TH CONSORTIUM MEETING ON 27TH AND 28TH OF JANUARY 2022
  • Advancing Clinical Research Capacity in Europe: Almari Conradie on TBAJ-587 and the ERA4TB Project [TB Alliance]

Categories

  • Event
  • News
  • Press

TWITTER

ERA4TB ProjectFollow

European Regimen Accelerator for Tuberculosis. Grant Agreement number: 853989 — ERA4TB

ERA4TB Project
Retweet on TwitterERA4TB Project Retweeted
16 May

The @IHIEurope @AMRAccelerator is a public-private partnership of 9 projects united to fight #AMR and #TB. Our #newsletter provides the best summary. Already sign up now and receive the next issue in your inbox: https://bit.ly/3vQ2bMX

#HealthForAll #OneHealth #StopSuperbugs

Reply on Twitter 1526111993282940928Retweet on Twitter 15261119932829409285Like on Twitter 15261119932829409284Twitter 1526111993282940928
Retweet on TwitterERA4TB Project Retweeted
10 May

El candidato(a) seleccionado se incorporaría al mayor proyecto a nivel europeo para el desarrollo de nuevos antibióticos contra la tuberculosis (https://era4tb.org/) @ARAID_ES @unizar https://twitter.com/amr_d2/status/1523974613545500672

D2AMR@amr_d2

Oferta de trabajo! Convocatoria PRI-019/2022 para el poryecto @IMI_ERA4TB. Técnico especialista apoyo investigación. Facultad Medicina y Centro EETs en @unizar https://sede.unizar.es/?app=touz&opcion=mostrar&id=46742 via @tramita_unizar Plazo de presentación de solicitudes del 11 al 17 de mayo 2022.

Reply on Twitter 1523982784896897025Retweet on Twitter 15239827848968970257Like on Twitter 15239827848968970257Twitter 1523982784896897025
Retweet on TwitterERA4TB Project Retweeted
6 May

The @IHIEurope @AMRAccelerator is all about public-private partnerships to tackle #TB and #AMR. Do you want to get an overview on what's new from all projects?Sign up to our newsletter and receive the next issue in your inbox: https://bit.ly/3vQ2bMX

#OneHealth #StopSuperbugs

Reply on Twitter 1522494233789280256Retweet on Twitter 15224942337892802561Like on Twitter 15224942337892802565Twitter 1522494233789280256
Retweet on TwitterERA4TB Project Retweeted
3 May

New @WHO guidelines have the potential to transform the TB treatment landscape with six-month standard. Read more from our statement on the WHO's Rapid Communication for drug-resistant #tuberculosis treatment: https://bit.ly/TBA-WHO-DR-TB #EndTB

Reply on Twitter 1521507157644128257Retweet on Twitter 152150715764412825714Like on Twitter 152150715764412825727Twitter 1521507157644128257
Retweet on TwitterERA4TB Project Retweeted
7 Apr

Are you at the @AMR_Conference today? 🏃 🏃 🏃 Go quick to the media table in the exhibition to grab your copy of the freshly printed @IMI_ERA4TB info sheet! The pile is getting smaller and smaller https://amr-accelerator.eu/project/era4tb/ #StopAMR #AntimicrobialResearch

Reply on Twitter 1512047071808872457Retweet on Twitter 15120470718088724578Like on Twitter 15120470718088724579Twitter 1512047071808872457
Load More...
Acknowledgement:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853989.
The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Global Alliance for TB Drug Development non profit organisation, Bill & Melinda Gates Foundation and University of Dundee.
Contact:
info@era4tb.org
The Project
  • About
  • Objectives
  • Ambitions
  • Structure
Consortium
  • Partners
  • Advisors
News
  • News
  • Newsletter
  • Events
  • Media
Result
  • Publications
  • Deliverables

© 2022 ERA4TB. About IMI - Disclaimer - Cookies Policy - Legal Notice

  • The Project
  • Consortium
  • News
    • Events
    • Press
    • Newsletter
    • Video Library
  • Results
  • TB Facts
  • SharePoint
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookies PolicyACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.